A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine. 

Semaglutide treatment was found to reduce healthcare costs significantly for patients with overweight or obesity and who had either heart failure or atherosclerotic cardiovascular disease, according to studies presented Nov. 3-6 at the Obesity Society's annual Obesity Week conference and reviewed Nov. 6 in the American Journal of Managed Care.

Researchers are starting to learn more about a rare but deadly side effect of immunotherapy cancer treatment, according to a study published Nov. 6 in Nature. 

Breast arterial calcifications are benign calcium buildups that in mammograms look like white parallel lines. Measuring these calcifications may improve cardiovascular risk in women, according to a study published Sept. 27 in JACC: Advances.

The American Heart Association will recognize eight leaders in cardiology at the organization's annual Scientific Sessions conference, set for Nov. 16-18. 

Sociocultural pressures of masculinity may influence whether men seek out cardiac care, according to a study published Oct. 25 in JAMA Network Open. 

California and Florida have the most top-ranked hospitals for pacemaker or defibrillator placement in the U.S., according to the WebMD Choice Awards.

The BiVACOR Total Artificial Heart is included on the "The Best Inventions of 2024" list published Oct. 30 in Time. 

CMS has proposed coverage of implantable pulmonary artery pressure sensors for the management of heart failure. 

Traditionally, patients with a failing heart valve were advised to return in six to 12 months, as physicians generally took a "wait and see" approach, but a new study suggests patients may benefit more if their valves are replaced immediately through a minimally invasive procedure.

Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. 22. Of those recipients, 50 hospitals were recognized for delivering superior clinical outcomes in vascular surgery.

A federal court has dismissed an antitrust lawsuit filed against Indianapolis based-Indiana University Health. The lawsuit was filed by vascular surgeon Ricardo Vasquez, MD, who alleged the health system engaged in anti-competitive behavior.

The U.S. economy could grow by $28 billion annually by 2040 if women's heart health was addressed equally to that of men. 

Yale New Haven (Conn.) Health and the Yale School of Medicine have appointed Marc Pelletier, MD, division chief of cardiac surgery for the department of surgery and section chief of cardiac surgery at Yale New Haven Hospital as well as physician-in-chief of cardiac surgery for the health system's Heart and Vascular Center. 

Patient participation in cardiac rehabilitation programs is an essential part of reducing the risk of a second cardiovascular disease, according to a study published Oct. 26 in Cureus. 

Manhasset, N.Y.-based North Shore University Hospital had the lowest 30-day mortality rate for coronary artery bypass graft patients in the U.S. between July 1, 2020, and June 30, 2023, according to CMS data released July 31.

Cincinnati Children's and Indianapolis-based Peyton Manning Children's Hospital at Ascension St. Vincent have jointly appointed Roosevelt Bryant III, MD, chief of pediatric and congenital heart surgery.

Payer status, income and age all had an increased association with mortality for patients seeking treatment for cardiac arrest at emergency departments, according to a study published Sept. 20 in the Journal of Clinical Medicine. 

West Orange, N.J.-based RWJBarnabas Health has appointed Conor Barrett, MD, senior vice president and chief clinical officer of heart and vascular services.

The American Heart Association and American Stroke Association have updated the organizations' stroke prevention guidelines to include gender-focused insights and GLP-1 recommendations. The new guidelines were published Oct. 21 in Stroke.